Latest ResMed News & Updates

See the latest news and media coverage for ResMed. We track all announcements, press releases, and industry mentions in real time, all in one place.

ResMed

Medical technology company for sleep and respiratory care

resmed.com

Headquarters: San Diego, United States
Company type: Public company
Number of employees: 9,000–10,000

Last updated Today

Latest news about ResMed

In short: ResMed delivered strong Q3 2026 financial results, completed the $340 million acquisition of Noctrix Health, and appointed a new CFO.

Company announcements

June 1 ResMed

ResMed completes acquisition of Noctrix Health

The deal adds Nidra TOMAC therapy for Restless Legs Syndrome.

May 7 ResMed

ResMed CEO discusses AI and GLP-1 innovations

Mick Farrell highlights AI for personalized sleep experiences via Smart Comfort and DAWN. GLP-1 therapies boost sleep apnea diagnosis and CPAP engagement for 2.1+ million patients.

May 4 ResMed

ResMed announces ENS certification of AirView

The certification, granted after an independent audit, confirms compliance with strict cybersecurity requirements to protect systems and patient data.

April 30 ResMed

ResMed appoints Aaron Bloomer CFO

Brett Sandercock retires effective May 4, 2026; Bloomer joins from Exact Sciences and Sandercock will advise through 2027.

Media coverage

Yesterday MSN

ResMed downgraded at Morgan Stanley on Philips re-entry and GLP-1 headwinds

ResMed (RMD) shares fell in the premarket on Wednesday after Morgan Stanley downgraded the respiratory device maker, citing headwinds from the GLP-1 class of weight-loss...

June 15 Yahoo Finance

ResMed (RMD) Stock Valuation Check After Mixed Returns And Undervaluation Signals

Recent performance snapshot ResMed (RMD) has drawn investor attention after a period of mixed share performance, with the stock up about 1% over the past...

June 11 MSN

ResMed added as new short idea at Hedgeye

ResMed (RMD) was added as a new short idea with the potential for a 30% decline in its shares. "As GLP-1s get cheaper, oral and...

June 9 Investing.com

ResMed chairman & CEO Michael Farrell sells $968k in stock By Investing.com

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may...

Never miss news about ResMed

Track ResMed and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.